Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

The problems surrounding leishmaniasis are changing. An increase in travel, the Indian and Sudanese epidemics of visceral leishmaniasis, parasite resistance to antimony and the emergence of AIDS-related leishmaniasis have all increased the urgency for new drugs, and led to reappraisals of the old ones, as discussed here by Piero Olliaro and Anthony Bryceson.

Original publication

DOI

10.1016/0169-4758(93)90231-4

Type

Journal

Parasitology today (Personal ed.)

Publication Date

09/1993

Volume

9

Pages

323 - 328

Addresses

Tropical Diseases Research, World Health Organisation, 20 Avenue Appia, CH-1211, Geneva 27, Switzerland.